Kratom Regulation: Addressing Rising Public Health Concerns

Reports of kratom-related poisonings in the United States increased by approximately 1,200% between 2015 and 2025, according to an analysis of National Poison Data System data published by the Centers for Disease Control and Prevention (CDC) on March 26, 2026.

The report indicates that exposure reports rose from 258 in 2015 to 3,434 in 2025, with a marked surge occurring throughout 2025.

Public health officials have identified a shift in how the substance is consumed as a primary driver of these safety concerns. While kratom was traditionally used in natural leaf preparations, there has been a recent move toward high-potency alkaloid extracts.

Clinical Outcomes and Risk Factors

The CDC analysis found that the most severe clinical outcomes were linked to multiple-substance exposure reports. These cases often involved the use of kratom in combination with antidepressants and other addictive substances.

Kratom, derived from the leaves of the tropical evergreen tree Mitragyna speciosa, is native to Southeast Asia. This proves traditionally consumed in that region for mood enhancement, pain relief, and the relief of opioid withdrawal symptoms.

The plant contains psychoactive compounds that interact with opioid receptors in the human body. In the United States, the substance is widely available in various forms and is frequently sold in convenience stores, gas stations, and vape shops.

Regulatory Challenges and Legislative Proposals

The rise in toxicity concerns and poisoning reports has led to ongoing debates among U.S. Lawmakers regarding whether to regulate or ban the substance entirely.

Legislative proposals have emerged that would require the Secretary to conduct at least one public hearing to evaluate the safety of kratom products. According to Congressional Research Service documentation, these hearings would be required to address specific topics, including the potential benefits of using kratom and the possible adverse health impacts that could result from a total ban.

The regulatory environment remains complex as officials struggle to keep pace with the dangers associated with the drug’s availability and the emergence of new product forms, such as unregulated kratom drinks.

Public Health Implications

Research into the pharmacology, toxicology, and epidemiology of kratom’s alkaloids is ongoing to help address existing regulatory gaps in the United States.

Public health experts suggest that continuous surveillance is necessary to identify high-risk patterns of use. This data is intended to guide clinical care and public health education, particularly for individuals engaging in multisubstance use.

The CDC maintains that kratom use remains a significant public health concern due to the evolution of the product from a natural leaf to high-potency versions.